Imaging genetics and psychiatric disorders

Current Molecular Medicine

Volumn 15, Issue 2, 2015, Pages 168-175

  Hashimoto, R ^a,b   Ohi, K ^b   Yamamori, H ^b   Yasuda, Y ^b   Fujimoto, M ^b   Umeda Yano, S ^b   Watanabe, Y ^b   Fukunaga, M ^a   Takeda, M ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bipolar disorder; Gene; Genome wide association study; Imaging genetics; Intermediate phenotype; Neuroimaging; Schizophrenia; Structural MRI

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; ZINC FINGER PROTEIN; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; COMT PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; ZNF804A PROTEIN, HUMAN;

ARTICLE; BIPOLAR DISORDER; BRAIN FUNCTION; CHROMOSOME TRANSLOCATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENETICS; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INDEPENDENT COMPONENT ANALYSIS; MENTAL DISEASE; META ANALYSIS (TOPIC); MULTIFACTORIAL INHERITANCE; NEUROIMAGING; PHENOTYPE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; CHEMISTRY; CHROMOSOME 12; COOPERATION; DEVICES; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; HIPPOCAMPUS; MEDICAL GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; ULTRASTRUCTURE;

BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOL O-METHYLTRANSFERASE; CHROMOSOMES, HUMAN, PAIR 12; COOPERATIVE BEHAVIOR; GENE EXPRESSION; GENETICS, MEDICAL; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HIPPOCAMPUS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NEUROIMAGING; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84930976316     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524015666150303104159     Document Type: Article

References (77)

1. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 2006; 7: 818-27.
2. Keshavan MS, Prasad KM, Pearlson G. Are brain structural abnormalities useful as endophenotypes in schizophrenia? Int Rev Psychiatry 2007; 19: 397-406.
3. van Haren NE, Bakker SC, Kahn RS. Genes and structural brain imaging in schizophrenia. Curr Opin Psychiatry 2008; 21: 161-7.
4. Tan HY, Callicott JH, Weinberger DR. Prefrontal cognitive systems in schizophrenia: towards human genetic brain mechanisms. Cogn Neuropsychiatry 2009; 14: 277-98.
5. Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001; 98: 6917-22.
6. Cerasa A, Gioia MC, Labate A, et al. Impact of catechol-Omethyltransferase Val(108/158) Met genotype on hippocampal and prefrontal gray matter volume. Neuroreport 2008; 19: 405-8.
7. Honea R, Verchinski BA, Pezawas L, et al. Impact of interacting functional variants in COMT on regional gray matter volume in human brain. Neuroimage 2009; 45: 44-51.
8. Mechelli A, Tognin S, McGuire PK, et al. Genetic vulnerability to affective psychopathology in childhood: a combined voxelbased morphometry and functional magnetic resonance imaging study. Biol Psychiatry 2009; 66: 231-7.
9. Taylor WD, Zuchner S, Payne ME, et al. The COMT Val158Met polymorphism and temporal lobe morphometry in healthy adults. Psychiatry Res 2007; 155: 173-7.
10. Barnes A, Isohanni M, Barnett JH, et al. No association of COMT (Val158Met) genotype with brain structure differences between men and women. PLoS One 2009; 7: e33964.
11. Wang Y, Li J, Chen C, et al. COMT rs4680 Met is not always the 'smart allele': Val allele is associated with better working memory and larger hippocampal volume in healthy Chinese. Genes Brain Behav 2013; 12: 323-9.
12. McIntosh AM, Baig BJ, Hall J, et al. Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis. Biol Psychiatry 2007; 61: 1127-34.
13. Ohnishi T, Hashimoto R, Mori T, et al. The association between the Val158Met polymorphism of the catechol-Omethyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 2006; 129: 399-410.
14. Ho BC, Wassink TH, O'Leary DS, Sheffield VC, Andreasen NC. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol Psychiatry 2005; 10: 229, 87-98.
15. Kates WR, Antshel KM, Abdulsabur N, et al. A gendermoderated effect of a functional COMT polymorphism on prefrontal brain morphology and function in velo-cardio-facial syndrome (22q11.2 deletion syndrome). Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 274-80.
16. Rybakowski JK. BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia. Pharmacogenomics 2008; 9: 1589-93.
17. Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-69.
18. Molendijk ML, Bus BA, Spinhoven P, et al. A systematic review and meta-analysis on the association between BDNF val(66)met and hippocampal volume--a genuine effect or a winners curse? Am J Med Genet B Neuropsychiatr Genet 2012; 159B: 731-40.
19. Aas M, Haukvik UK, Djurovic S, et al. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses. Prog Neuropsychopharmacol Biol Psychiatry 2013; 46: 181-8.
20. Carballedo A, Morris D, Zill P, et al. Brain-derived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volume. Am J Med Genet B Neuropsychiatr Genet 2013; 162B: 183-90.
21. Gatt JM, Nemeroff CB, Dobson-Stone C, et al. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 2009; 14: 681-95.
22. Gerritsen L, Tendolkar I, Franke B, et al. BDNF Val66Met genotype modulates the effect of childhood adversity on subgenual anterior cingulate cortex volume in healthy subjects. Mol Psychiatry 2012; 17: 597-603.
23. Ho BC, Andreasen NC, Dawson JD, Wassink TH. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry 2007; 164: 1890-9.
24. Nemoto K, Ohnishi T, Mori T, et al. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett 2006; 397: 25-9.
25. Hashimoto R, Hirata Y, Asada T, et al. Effect of the brainderived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease. Genes Brain Behav 2009; 8: 43-52.
26. Blackwood DH, Fordyce A, Walker MT, et al. Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001; 69: 428-33.
27. Chubb JE, Bradshaw NJ, Soares DC, Porteous DJ, Millar JK. The DISC locus in psychiatric illness. Mol Psychiatry 2008; 13: 36-64.
28. Hashimoto R, Numakawa T, Ohnishi T, et al. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet 2006; 15: 3024-33.
29. Duff BJ, Macritchie KA, Moorhead TW, Lawrie SM, Blackwood DH. Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review. Schizophr Res 2013; 147: 1-13.
30. Donohoe G, Frodl T, Morris D, et al. Reduced occipital and prefrontal brain volumes in dysbindin-associated schizophrenia. Neuropsychopharmacology 2010; 35: 368-73.
31. Dutt A, McDonald C, Dempster E, et al. The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis. Psychol Med 2009; 39: 1783-97.
32. Narr KL, Szeszko PR, Lencz T, et al. DTNBP1 is associated with imaging phenotypes in schizophrenia. Hum Brain Mapp 2009; 30: 3783-94.
33. Trost S, Platz B, Usher J, et al. The DTNBP1 (dysbindin-1) gene variant rs2619522 is associated with variation of hippocampal and prefrontal grey matter volumes in humans. Eur Arch Psychiatry Clin Neurosci 2013; 263: 53-63.
34. Gruber O, Falkai P, Schneider-Axmann T, et al. Neuregulin-1 haplotype HAP(ICE) is associated with lower hippocampal volumes in schizophrenic patients and in non-affected family members. J Psychiatr Res 2008; 43: 1-6.
35. Tosato S, Bellani M, Bonetto C, et al. Is neuregulin 1 involved in determining cerebral volumes in schizophrenia? Preliminary results showing a decrease in superior temporal gyrus volume. Neuropsychobiology 2012; 65: 119-25.
36. Ohi K, Hashimoto R, Yasuda Y, et al. The AKT1 gene is associated with attention and brain morphology in schizophrenia. World J Biol Psychiatry 2013; 14: 100-13.
37. Tan HY, Nicodemus KK, Chen Q, et al. Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. J Clin Invest 2008; 118: 2200-8.
38. Schwab SG, Wildenauer DB. Genetics of psychiatric disorders in the GWAS era: an update on schizophrenia. Eur Arch Psychiatry Clin Neurosci 2013; 263 Suppl 2: S147-54.
39. O'Donovan MC, Craddock N, Norton N, et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008; 40: 1053-5.
40. Lencz T, Szeszko PR, DeRosse P, et al. A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes. Neuropsychopharmacology 2010; 35: 2284-91.
41. Donohoe G, Rose E, Frodl T, et al. ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia. Neuroimage 2011; 54: 2132-7.
42. Wassink TH, Epping EA, Rudd D, et al. Influence of ZNF804a on brain structure volumes and symptom severity in individuals with schizophrenia. Arch Gen Psychiatry 2012; 69: 885-92.
43. Stefansson H, Ophoff RA, Steinberg S, et al. Common variants conferring risk of schizophrenia. Nature 2009; 460: 744-7.
44. Li J, Pak JH, Huang FL, Huang KP. N-methyl-D-aspartate induces neurogranin/RC3 oxidation in rat brain slices. J Biol Chem 1999; 274: 1294-300.
45. Ohi K, Hashimoto R, Yasuda Y, et al. Impact of the genome wide supported NRGN gene on anterior cingulate morphology in schizophrenia. PLoS One 2012; 7: e29780.
46. Rose EJ, Morris DW, Fahey C, et al. The effect of the neurogranin schizophrenia risk variant rs12807809 on brain structure and function. Twin Res Hum Genet 2012; 15: 296-303.
47. Walton E, Geisler D, Hass J, et al. The impact of genomewide supported schizophrenia risk variants in the neurogranin gene on brain structure and function. PLoS One 2013; 8: e76815.
48. Walters JT, Rujescu D, Franke B, et al. The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up. Am J Psychiatry 2013; 170: 877-85.
49. Consortium SPG-WASG. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969-76.
50. Ohi K, Hashimoto R, Yamamori H, et al. The impact of the genome-wide supported variant in the cyclin M2 gene on gray matter morphology in schizophrenia. Behav Brain Funct 2013; 9: 40.
51. Rose EJ, Hargreaves A, Morris D, et al. Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style. Br J Psychiatry 2014; 204: 115-21.
52. Rose EJ, Morris DW, Hargreaves A, et al. Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253. Am J Med Genet B Neuropsychiatr Genet 2013; 162B: 530-7.
53. Ferreira MA, O'Donovan MC, Meng YA, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008; 40: 1056-8.
54. Wang F, McIntosh AM, He Y, Gelernter J, Blumberg HP. The association of genetic variation in CACNA1C with structure and function of a frontotemporal system. Bipolar Disord 2011; 13: 696-700.
55. Cassidy C, Buchy L, Bodnar M, et al. Association of a risk allele of ANK3 with cognitive performance and cortical thickness in patients with first-episode psychosis. J Psychiatry Neurosci 2014; 39: 31-9.
56. Tesli M, Egeland R, Sonderby IE, et al. No evidence for association between bipolar disorder risk gene variants and brain structural phenotypes. J Affect Disord 2013; 151: 291-7.
57. Shen L, Kim S, Risacher SL, et al. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. Neuroimage 2010; 53: 1051-63.
58. Stein JL, Hua X, Lee S, et al. Voxelwise genome-wide association study (vGWAS). Neuroimage 2010; 53: 1160-74.
59. Stein JL, Hua X, Morra JH, et al. Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage 2010; 51: 542-54.
60. Thompson PM, Stein JL, Medland SE, et al. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav 2014; 8: 153-82.
61. Psaty BM, O'Donnell CJ, Gudnason V, et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective metaanalyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet 2009; 2: 73-80.
62. Schumann G, Loth E, Banaschewski T, et al. The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry 2010; 15: 1128-39.
63. Stein JL, Medland SE, Vasquez AA, et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 2012; 44: 552-61.
64. Bis JC, DeCarli C, Smith AV, et al. Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet 2012; 44: 545-51.
65. Nymberg C, Jia T, Ruggeri B, Schumann G. Analytical strategies for large imaging genetic datasets: experiences from the IMAGEN study. Ann N Y Acad Sci 2013; 1282: 92-106.
66. Hass J, Walton E, Kirsten H, et al. A Genome-Wide Association Study Suggests Novel Loci Associated with a Schizophrenia-Related Brain-Based Phenotype. PLoS One 2013; 8: e64872.
67. Hashimoto R, Ikeda M, Yamashita F, et al. Common variants at 1p36 are associated with superior frontal gyrus volume. Transl Psychiatry 2014; 4: e472.
68. Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-52.
69. Lencz T, Knowles E, Davies G, et al. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT). Mol Psychiatry 2014; 19: 168-74.
70. Terwisscha van Scheltinga AF, Bakker SC, van Haren NE, et al. Genetic schizophrenia risk variants jointly modulate total brain and white matter volume. Biol Psychiatry 2013; 73: 525-31.
71. Ohi K, Hashimoto R, Ikeda M, et al. Genetic risk variants of schizophrenia associated with left superior temporal gyrus volume. Cortex 2014; 58: 23-6.
72. Thompson PM, Martin NG, Wright MJ. Imaging genomics. Curr Opin Neurol 2010; 23: 368-73.
73. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. Lithium-induced increase in human brain grey matter. Lancet 2000; 356: 1241-2.
74. Lieberman JA, Tollefson GD, Charles C, et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 2005; 62: 361-70.
75. Franklin TR, Wang Z, Shin J, et al. A VBM study demonstrating 'apparent' effects of a single dose of medication on T1-weighted MRIs. Brain Struct Funct 2013; 218: 97-104.
76. Meda SA, Narayanan B, Liu J, et al. A large scale multivariate parallel ICA method reveals novel imaginggenetic relationships for Alzheimer's disease in the ADNI cohort. Neuroimage 2012; 60: 1608-21.
77. Ge T, Feng J, Hibar DP, Thompson PM, Nichols TE. Increasing power for voxel-wise genome-wide association studies: the random field theory, least square kernel machines and fast permutation procedures. Neuroimage 2012; 63: 858-73.